CW August 2000
Volume 9Issue Number 8 August 2000 ISSN 10593802 A Better Treatment Regimen for Elderly Lung Cancer PatientsElderly patients with advanced lung cancer who cannot tolerate combination chemotherapy respond well to weekly dose of docetaxel (Taxotere®). This weekly moderate dose instead of high dose every 3 weeks also offers advantages regarding toxicity. Blood-related adverse side effects are markedly reduced with the weekly schedule.
Go to Previous Page Go to Next Page Source & Additional Reading J. D. Hainsworth et al., Cancer, July 15, 2000. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW August 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
